Edgewise Therapeutics, Inc. EWTX Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -38.1%-7.9pp | -34.2%+0.2pp | -30%+1.9pp | -27.4%+0.8pp | -30.3%-5.8pp | |
| Return on invested capital | -47.1%-9.0pp | -43.1%+5.0pp | -37.5%+3.9pp | -34.2%+1.8pp | -38%-7.0pp | |
| Liquidity | ||||||
| Current ratio | 22.6×+1.6× | 19.9×-0.1× | 26.5×+0.2× | 28.9×-1.4× | 21×-16.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | ||||||
| Book value per share | $4.60+1.9% | $5.07+2.1% | $5.30+1.6% | $5.61+2.8% | $4.52-26.1% | |
| Valuation | ||||||
| Market capitalization | $3.38B+61.3% | $2.63B+3.9% | $1.71B-31.8% | $1.55B-7.9% | $2.09B+31.1% | |
| Price / book | 6.9×+2.0× | 5×-0.5× | 3.1×-2.1× | 2.6×-0.7× | 4.9×+1.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Edgewise Therapeutics, Inc.'s ratios come from?
- Every ratio is computed from Edgewise Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.